SG
Sanjay Gupta
About Sanjay Gupta
Data last updated:
Sanjay Gupta is a Director at Skymap Pharmaceuticals Private Limited (since 2006), Director at Glensmith Labs Private Limited (since 2014) and Director at Torrvis Pharmaceuticals Private Limited (since 2020), and holds 11 more current directorships. The companies operate in Pharma, Packaging and Real Estate and Construction. The 9 current companies with reported revenue have a combined latest revenue of ₹604 Cr; the largest is Skymap Pharmaceuticals Private Limited at ₹409 Cr (FY 2025). Earlier, Sanjay Gupta was a Director at Kash Medicare Private Limited (2008–2013) and Designated Partner at Nortis Lifesciences Llp (from 2017) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Skymap Pharmaceuticals Private Limited U24233DL2006PTC150088 | Director | 24 Jun 2006 | 2006 | ₹409 Cr (FY 2025) | Active |
 Glensmith Labs Private Limited U24100DL2014PTC273104 | Director | 12 Nov 2014 | 2014 | ₹121 Cr (FY 2025) | Active |
 Torrvis Pharmaceuticals Private Limited U24233DL2020PTC374452 | Director | 11 Dec 2020 | 2020 | ₹31.91 Cr (FY 2025) | Active |
| Skymap Packaging Private Limited U21029DL2022PTC408733 | Director | 22 Dec 2022 | 2022 | ₹29.31 Cr (FY 2025) | Active |
| Datt Infrastructure And Services Private Limited U74999UR1995PTC012824 | Director | 20 Feb 2022 | 1995 | ₹6.10 Cr (FY 2025) | Active |
| Nortis Infrastructure Private Limited U70109DL2017PTC324823 | Director | 11 Oct 2017 | 2017 | ₹2.94 Cr (FY 2025) | Active |
| Organic Secrets Private Limited U24230DL2020PTC371542 | Director | 14 Oct 2020 | 2020 | ₹2.73 Cr (FY 2025) | Active |
| Manek Tradex Private Limited U51909DL2006PTC152567 | Director | 19 Jul 2010 | 2006 | ₹1.44 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Kash Medicare Private Limited U51909DL2008PTC183790 | Director | 26 Sep 2008 | 2008 | ₹163 Cr (FY 2025) | Active |
| Nortis Lifesciences Llp AAJ-3316 | Designated Partner | 04 May 2017 | 2017 | Converted And Dissolved | |
| Mks Pharma Limited U24232DL2005PLC139202 | Whole-Time Director | 01 Aug 2005 | 2005 | ₹27.73 Cr (FY 2017) | Amalgamated |
| Skymap Healthcare Private Limited U33116DL2003PTC316235 | Director | 22 Dec 2015 | 2003 | ₹65.96 Cr (FY 2022) | Amalgamated |
| Mks Healthcare Llp AAF-1872 | Designated Partner | 19 Nov 2015 | 2015 | ₹299 Cr (FY 2023) | Converted And Dissolved |
| Cosmax Pharma Llp AAF-1873 | Designated Partner | 19 Nov 2015 | 2015 | ₹38.31 Cr (FY 2023) | Converted And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Gupta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manish Garg | 07057564 | Skymap Pharmaceuticals Private Limited , Glensmith Labs Private Limited and 3 more | Director |
| Vinod Kumar Gupta | 07962313 | Skymap Pharmaceuticals Private Limited , Datt Infrastructure And Services Private Limited | Director |
| Meenakshi Gupta | 07248722 | Torrvis Pharmaceuticals Private Limited , Skymap Packaging Private Limited and 8 more | Director |
| Ganesh Kumar Pandagre | 10053332 | Skymap Packaging Private Limited | Director |
| Rajat Gupta | 07522363 | Cosmax Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Gupta
Sanjay Gupta currently holds 14 directorships: Skymap Pharmaceuticals Private Limited (Director, since 24 Jun 2006, revenue ₹409 Cr (FY 2025)); Glensmith Labs Private Limited (Director, since 12 Nov 2014, revenue ₹121 Cr (FY 2025)); Torrvis Pharmaceuticals Private Limited (Director, since 11 Dec 2020, revenue ₹31.91 Cr (FY 2025)); Skymap Packaging Private Limited (Director, since 22 Dec 2022, revenue ₹29.31 Cr (FY 2025)); Datt Infrastructure And Services Private Limited (Director, since 20 Feb 2022, revenue ₹6.10 Cr (FY 2025)); and 9 more.
Sanjay Gupta was first appointed on 01 Aug 2005 as Whole-Time Director at Mks Pharma Limited. The most recent appointment on record is 13 Jun 2025 at Cosmax Pharma Private Limited.
The 9 current companies of Sanjay Gupta that report revenue have a combined latest revenue of ₹604 Cr: Skymap Pharmaceuticals Private Limited ₹409 Cr (FY 2025); Glensmith Labs Private Limited ₹121 Cr (FY 2025); Torrvis Pharmaceuticals Private Limited ₹31.91 Cr (FY 2025); Skymap Packaging Private Limited ₹29.31 Cr (FY 2025); Datt Infrastructure And Services Private Limited ₹6.10 Cr (FY 2025); and 4 more.
Sanjay Gupta held 6 earlier board appointments: Kash Medicare Private Limited (Director, 26 Sep 2008 to 30 Mar 2013); Nortis Lifesciences Llp (Designated Partner, from 04 May 2017); Mks Pharma Limited (Whole-Time Director, from 01 Aug 2005); Skymap Healthcare Private Limited (Director, from 22 Dec 2015); Mks Healthcare Llp (Designated Partner, from 19 Nov 2015); and 1 more.
The current boards of Sanjay Gupta's companies include Manish Garg (Skymap Pharmaceuticals Private Limited), Vinod Kumar Gupta (Skymap Pharmaceuticals Private Limited), Meenakshi Gupta (Torrvis Pharmaceuticals Private Limited), Ganesh Kumar Pandagre (Skymap Packaging Private Limited), Rajat Gupta (Cosmax Pharma Private Limited).